SHMN
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. It offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. The company also exports its products. SOHM, Inc. was founded in 2005 and is based in Corona, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | 0.00 | $299,216 | -$536,490 |
| 2025 Q3 | 0.00 | $376,005 | $2M |
| 2025 Q2 | 0.00 | $265,191 | -$2M |
| 2025 Q1 | 0.00 | $238,432 | — |
| 2024 Q4 | -0.00 | $350,145 | $89,860 |
| 2024 Q3 | 0.00 | $256,751 | -$50,540 |
| 2024 Q2 | 0.00 | $252,241 | $55,200 |
| 2024 Q1 | -0.00 | $89,894 | -$92,620 |